GMAB
Genmab A/S
Latest News for GMAB
Genmab ( ($GMAB) ) has provided an announcement. On January 29, 2026, Genmab A/S announced that its board had granted 32,806 restricted stock units......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF – Research Report) and Gen......
Genmab ( ($GMAB) ) has shared an update. On January 21, 2026, Genmab reported that 2025 worldwide net trade sales of the multiple myeloma therapy D......
In a report released on January 19, Jon Berggren from Kepler Capital maintained a Hold rating on Genmab A/S, with a price target of DKK2,100.00. Th......
UBS analyst Xian Deng maintained a Buy rating on Genmab A/S today and set a price target of DKK2,750.00. Deng covers the Healthcare sector, focusin......
In a report released today, James Gordon CFA from Barclays maintained a Buy rating on Genmab A/S, with a price target of DKK2,500.00. The word on T......
Genmab ( ($GMAB) ) has shared an announcement. On January 16, 2026, Genmab reported topline Phase 3 results from its global EPCORE DLBCL-1 trial of......
In a report released today, Xian Deng from UBS maintained a Buy rating on Genmab A/S, with a price target of DKK2,750.00. According to TipRanks, De......
News data is sourced from MarketXLS API and updated regularly.
Showing 8 of 8 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GMAB | $33.27 | +2.0% | 880.30K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |